A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: against (297), vs. (65)

PRIVACY NOTICE_Synergy between PCI with TAXUS and Cardiac SurgeryREV - FINAL

Description
Synergy between PCI with TAXUS and Cardiac Surgery: SYNTAX Extended Survival (SYNTAXES) This is a privacy notice for pa
Url
/Media/Southampton-Clinical-Research/News-stories/PRIVACY-NOTICE-Synergy-between-PCI-with-TAXUS-and-Cardiac-SurgeryREV-FINAL.docx

GvHDProphylaxisMethotrexateTReplete

Description
Chemotherapy Protocol SUPPORT REGIMEN–GvHD PROPHYLAXIS METHOREXATE – T Replete Allograft Graft versus Host Disease (GvHD) Prophylaxis This regimen will only be
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/GvHDProphylaxisMethotrexateTReplete.pdf

Targeting-Shared-Mechanisms-Call-1

Description
Call for Applications: Targeting shared mechanisms in immune-mediated inflammatory diseases Introduction and rationale There
Url
/Media/Southampton-Clinical-Research/Downloads/Targeting-Shared-Mechanisms-Call-1.pdf

CladribineIV

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA CLADRIBINE (IV-5 day) Regimen • HCL – Cladribine (IV-5 day) Indication • Hairy cell leukaemia (this is an unl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/CladribineIV.pdf

Topotecan (1,8,15)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

Topotecan (1,8)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Se
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf

Topotecan (1,2,3,4,5)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3,
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf

InP-LEAM

Description
Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Inpatient Regimen Regimen Lymphoma – InP-LEAM (split)-Lomustine-Cytarabine-Etoposide
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-LEAM.pdf

B-AVD (Brentuximab vedotin-Dacarbazine-Doxorubicin-Vinblastine)

Description
Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN-DACARBAZINE-DOXORUBICIN-VINBLASTINE (B- AVD) Regimen • Lymphoma – Brentuximab vedotin - Dacarbazine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/B-AVD-Brentuximab-vedotin-Dacarbazine-Doxorubicin-Vinblastine.pdf

AmB LEAM (split)-Lomustine-Cytarabine-Etoposide-Melphalan

Description
Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only and will onl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LEAM-split-Lomustine-Cytarabine-Etoposide-Melphalan.pdf
1 to 10 of 233
Previous 1 2 3 4 5 … Next